Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

SELL
$129.72 - $159.85 $3,632 - $4,475
-28 Reduced 1.24%
2,236 $0
Q3 2022

Oct 14, 2022

BUY
$126.59 - $161.18 $121,779 - $155,055
962 Added 73.89%
2,264 $302,000
Q2 2022

Jul 12, 2022

SELL
$141.59 - $168.66 $85,378 - $101,701
-603 Reduced 31.65%
1,302 $203,000
Q1 2022

Apr 18, 2022

BUY
$129.64 - $160.7 $246,964 - $306,133
1,905 New
1,905 $297,000
Q3 2021

Oct 08, 2021

SELL
$128.64 - $184.79 $172,634 - $247,988
-1,342 Closed
0 $0
Q4 2020

Jan 25, 2021

BUY
$140.71 - $165.05 $188,832 - $221,497
1,342 New
1,342 $221,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Golden Green, Inc. Portfolio

Follow Golden Green, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Golden Green, Inc. with notifications on news.